Building Blocks uses MK-4 for its rapid tissue uptake, strong clinical data, and alignment with the high-dose D3 protocol
Weight loss was associated with improvements in: Blood pressure Lipid profiles Sleep apnoea Joint pain Quality of life These findings led regulatory bodies to approve semaglutide (Wegovy) and tirzepatide (Zepbound) for obesity treatment, even in the absence of diabetes signalling a paradigm shift in how weight and metabolic risk are medically managed
Retrieved 18 August 2014
Back Sheridan, C (14 April 2025) 'Not just obesity: GLP-1 receptor agonists advance on addiction', Nature Biotechnology , 43, 455-47.Back Sims, EK, Carr, ALJ, Oram, RA, et al (15 July 2022) '100 years of insulin: celebrating the past, present and future of diabetes therapy', Nature Medicine , 27/7, 1154-64
In the pancreas, semaglutide stimulates insulin secretion in a glucose-dependent manner meaning it triggers insulin release when blood glucose is elevated, but not during normoglycemia, which substantially reduces the risk of hypoglycemia compared to older antidiabetic agents
They ate skin-on chicken, simmered soup bones for hours, and made use of every part of the animal
